Hugh Graham

Hugh Graham has extensive work experience in the field of biotechnology and pharmaceutical manufacturing. Hugh has held various roles and positions in different companies throughout their career.

From 2018 to present, Graham has been working as the Director of Cell Culture Sciences at MacroGenics, Inc. Here, they lead a group of scientists and engineers, supporting the development and production of antibody-based therapeutics.

Prior to that, from 2012 to 2017, Graham worked at Bristol-Myers Squibb. Hugh held multiple roles, including Associate Director of Manufacturing Technology and Senior Scientist. In these positions, they were responsible for process improvement projects, lab studies, and CMC documentation, among other tasks, in support of commercial and late-stage clinical manufacturing operations.

Before Bristol-Myers Squibb, Graham worked at Bayer HealthCare as a Senior Process Development Engineer from 2008 to 2012. Hugh also served as the Head of Upstream Manufacturing at Raven biotechnologies, Inc. from 2005 to 2008, where they led a team involved in monoclonal antibody production and research.

Graham began their career at Exelixis in 1999 as a Senior Scientist, working on various projects in the fields of oncology, agbio, and metabolism. Hugh led a team that produced reagent proteins using different expression systems and fermentor systems.

In 1998, Graham worked as a Scientist at MetaXen LLC, where they focused on the production and purification of recombinant reagent proteins.

Overall, Graham's work experience highlights their expertise in cell culture sciences, manufacturing technology, process development, and production of biologics and therapeutic agents.

Hugh Graham obtained a B.Sc. (Hons) degree in Chemical Engineering from the University of Surrey, where they attended from 1977 to 1981. Later, from 1990 to 1998, they pursued further education at Colorado State University, where they earned a Ph.D. and M.S. in Chemical Engineering.